dc.contributorUniversidade Estadual Paulista (UNESP)
dc.contributorUniversidade de São Paulo (USP)
dc.date.accessioned2022-04-28T20:41:58Z
dc.date.accessioned2022-12-20T01:58:33Z
dc.date.available2022-04-28T20:41:58Z
dc.date.available2022-12-20T01:58:33Z
dc.date.created2022-04-28T20:41:58Z
dc.date.issued2008-06-24
dc.identifierPhysiological Research, v. 57, n. 1, p. 109-118, 2008.
dc.identifier0862-8408
dc.identifierhttp://hdl.handle.net/11449/225180
dc.identifier2-s2.0-45349090863
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5405310
dc.description.abstractDopamine (DA) is known as a primary regulator of prolactin secretion (PRL) and angiotensin II (Ang II) has been recognized as one brain inhibitory factor of this secretion. In this work, estrogen-primed or unprimed ovariectomized rats were submitted to the microinjection of saline or Ang II after previous microinjection of saline or of DA antagonist (haloperidol, sulpiride or SCH) both in the medial preoptic area (MPOA). Our study of these interactions has shown that 1) estrogen-induced PRL secretion is mediated by Ang II and DA actions in the MPOA, i.e. very high plasma PRL would be prevented by inhibitory action of Ang II, while very low levels would be prevented in part by stimulatory action of DA through D2 receptors, 2) the inhibitory action of Ang II depends on estrogen and is mediated in part by inhibitory action of DA through D1 receptors and in other part by inhibition of stimulatory action of DA through D2 receptors. © 2008 Institute of Physiology v.v.i., Academy of Sciences of the Czech Republic.
dc.languageeng
dc.relationPhysiological Research
dc.sourceScopus
dc.subjectAngiotensin II
dc.subjectDopaminergic antagonists
dc.subjectEstrogen
dc.subjectMedial preoptic area
dc.subjectProlactin
dc.titleActions of angiotensin II and dopamine in the medial preoptic area on prolactin secretion
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución